India · Delayed Price · Currency is INR Brooks Laboratories Company Description
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally.
It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections.
It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries.
In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs.
It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa.
Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
| Country | India |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 347 |
| CEO | Prashant Rathi |
Contact Details
Address: 201, The Summit Business Park Mumbai, Maharashtra 400093 India | |
| Phone | 91 22 6907 3100 |
| Website | brookslabs.net |
Stock Details
| Ticker Symbol | BROOKS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE650L01011 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Krutika Mohan Rane | Company Secretary and Compliance Officer |
| Dr. Durga Shankar Maity M.Sc. | Whole Time Director |
| Rajesh Mahajan MBA | President of Trading |
| Atul Ranchal PGDFMT | President of Corporate Strategy |
| Bhushan Singh Rana | Whole-Time Director |
| Nikhil Anand Verma | Vice President of Sales and Marketing |